Last month, FDA approved the 3rd generic liraglutide injection, following up from it's 1st generic approval for this GLP-1 receptor agonist drug just 9 months earlier
Oct 26: Theres a new treatment on the immediate horizon for patients with Duchenne muscular dystrophy after the FDA approved Santhera Pharmaceuticals vamorolonenow Agamree
It is the most-studied component of the KLOW blend and the dominant component at 50mg, researched primarily for cytoprotective, pro-angiogenic, and anti-inflammatory properties in preclinical models
Professor Chen Wei, Department ofClinical Nutrition, Chinese Academy of Medical Sciences & PekingUnion Medical College, said: "In view of the limited clinical status ofdrugs approved for obesity treatment in China over the past 20 years, newmedical weight loss drugs can provide patients with safe, effective andconvenient treatment options, and can help Chinese obese patientsscientifically manage their weight and related disease risks and improve theirquality of life, which has a profound impact on the clinical practice ofobesity and related diseases." Reference: 1
L-Carnitine 1000 delivers a research-backed dose of L-Carnitine L-Tartrate to support the transport of fatty acids into the mitochondria, where they are converted into usable energy
